P2Y2R deficiency attenuates experimental autoimmune uveitis development.

We aimed to study the role of the nucleotide receptor P2Y2R in the development of experimental autoimmune uveitis (EAU). EAU was induced in P2Y2+/+ and P2Y2-/- mice by immunization with IRBP peptide or by adoptive transfer of in vitro restimulated semi-purified IRBP-specific enriched T lymphocytes f...

Full description

Bibliographic Details
Main Authors: Lia Judice M Relvas, Maya Makhoul, Remi Dewispelaere, Laure Caspers, Didier Communi, Jean-Marie Boeynaems, Bernard Robaye, Catherine Bruyns, François Willermain
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4334221?pdf=render
id doaj-8cb303d96e21438aa5da4eba128166af
record_format Article
spelling doaj-8cb303d96e21438aa5da4eba128166af2020-11-25T02:22:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01102e011651810.1371/journal.pone.0116518P2Y2R deficiency attenuates experimental autoimmune uveitis development.Lia Judice M RelvasMaya MakhoulRemi DewispelaereLaure CaspersDidier CommuniJean-Marie BoeynaemsBernard RobayeCatherine BruynsFrançois WillermainWe aimed to study the role of the nucleotide receptor P2Y2R in the development of experimental autoimmune uveitis (EAU). EAU was induced in P2Y2+/+ and P2Y2-/- mice by immunization with IRBP peptide or by adoptive transfer of in vitro restimulated semi-purified IRBP-specific enriched T lymphocytes from spleens and lymph nodes isolated from native C57Bl/6 or P2Y2+/+ and P2Y2-/- immunized mice. Clinical and histological scores were used to grade disease severity. Splenocytes and lymph node cell phenotypes were analyzed using flow cytometry. Semi-purified lymphocytes and MACS-purified CD4+ T lymphocytes from P2Y2+/+ and P2Y2-/- immunized mice were tested for proliferation and cytokine secretion. Our data show that clinical and histological scores were significantly decreased in IRBP-immunized P2Y2-/- mice as in P2Y2-/- mice adoptively transfered with enriched T lymphocytes from C57Bl/6 IRBP-immunized mice. In parallel, naïve C57Bl/6 mice adoptively transferred with T lymphocytes from P2Y2-/- IRBP-immunized mice also showed significantly less disease. No differences in term of spleen and lymph node cell recruitment or phenotype appeared between P2Y2-/- and P2Y2+/+ immunized mice. However, once restimulated in vitro with IRBP, P2Y2-/- T cells proliferate less and secrete less cytokines than the P2Y2+/+ one. We further found that antigen-presenting cells of P2Y2-/- immunized mice were responsible for this proliferation defect. Together our data show that P2Y2-/- mice are less susceptible to mount an autoimmune response against IRBP. Those results are in accordance with the danger model, which makes a link between autoreactive lymphocyte activation, cell migration and the release of danger signals such as extracellular nucleotides.http://europepmc.org/articles/PMC4334221?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Lia Judice M Relvas
Maya Makhoul
Remi Dewispelaere
Laure Caspers
Didier Communi
Jean-Marie Boeynaems
Bernard Robaye
Catherine Bruyns
François Willermain
spellingShingle Lia Judice M Relvas
Maya Makhoul
Remi Dewispelaere
Laure Caspers
Didier Communi
Jean-Marie Boeynaems
Bernard Robaye
Catherine Bruyns
François Willermain
P2Y2R deficiency attenuates experimental autoimmune uveitis development.
PLoS ONE
author_facet Lia Judice M Relvas
Maya Makhoul
Remi Dewispelaere
Laure Caspers
Didier Communi
Jean-Marie Boeynaems
Bernard Robaye
Catherine Bruyns
François Willermain
author_sort Lia Judice M Relvas
title P2Y2R deficiency attenuates experimental autoimmune uveitis development.
title_short P2Y2R deficiency attenuates experimental autoimmune uveitis development.
title_full P2Y2R deficiency attenuates experimental autoimmune uveitis development.
title_fullStr P2Y2R deficiency attenuates experimental autoimmune uveitis development.
title_full_unstemmed P2Y2R deficiency attenuates experimental autoimmune uveitis development.
title_sort p2y2r deficiency attenuates experimental autoimmune uveitis development.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description We aimed to study the role of the nucleotide receptor P2Y2R in the development of experimental autoimmune uveitis (EAU). EAU was induced in P2Y2+/+ and P2Y2-/- mice by immunization with IRBP peptide or by adoptive transfer of in vitro restimulated semi-purified IRBP-specific enriched T lymphocytes from spleens and lymph nodes isolated from native C57Bl/6 or P2Y2+/+ and P2Y2-/- immunized mice. Clinical and histological scores were used to grade disease severity. Splenocytes and lymph node cell phenotypes were analyzed using flow cytometry. Semi-purified lymphocytes and MACS-purified CD4+ T lymphocytes from P2Y2+/+ and P2Y2-/- immunized mice were tested for proliferation and cytokine secretion. Our data show that clinical and histological scores were significantly decreased in IRBP-immunized P2Y2-/- mice as in P2Y2-/- mice adoptively transfered with enriched T lymphocytes from C57Bl/6 IRBP-immunized mice. In parallel, naïve C57Bl/6 mice adoptively transferred with T lymphocytes from P2Y2-/- IRBP-immunized mice also showed significantly less disease. No differences in term of spleen and lymph node cell recruitment or phenotype appeared between P2Y2-/- and P2Y2+/+ immunized mice. However, once restimulated in vitro with IRBP, P2Y2-/- T cells proliferate less and secrete less cytokines than the P2Y2+/+ one. We further found that antigen-presenting cells of P2Y2-/- immunized mice were responsible for this proliferation defect. Together our data show that P2Y2-/- mice are less susceptible to mount an autoimmune response against IRBP. Those results are in accordance with the danger model, which makes a link between autoreactive lymphocyte activation, cell migration and the release of danger signals such as extracellular nucleotides.
url http://europepmc.org/articles/PMC4334221?pdf=render
work_keys_str_mv AT liajudicemrelvas p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT mayamakhoul p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT remidewispelaere p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT laurecaspers p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT didiercommuni p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT jeanmarieboeynaems p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT bernardrobaye p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT catherinebruyns p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
AT francoiswillermain p2y2rdeficiencyattenuatesexperimentalautoimmuneuveitisdevelopment
_version_ 1724861353265463296